| scholarly article | Q13442814 |
| P50 | author | Lisa Knopf | Q114445400 |
| Brendan A Rich | Q114445401 | ||
| Laura M Onelio | Q114445402 | ||
| Daniel S Pine | Q87900255 | ||
| Ellen Leibenluft | Q91837313 | ||
| Melissa A Brotman | Q104138191 | ||
| Kenneth E Towbin | Q114445396 | ||
| Daniel P. Dickstein | Q41645149 | ||
| P2093 | author name string | Jan Willem Van Der Veen | |
| P2860 | cites work | Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness | Q28139650 |
| Response to lithium maintenance treatment in bipolar disorders: comparison of women and men | Q77790335 | ||
| The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s) | Q79482449 | ||
| Effectiveness of collaborative problem solving in affectively dysregulated children with oppositional-defiant disorder: initial findings | Q81183545 | ||
| Treatment of depression in children and adolescents | Q81194279 | ||
| A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania | Q82844588 | ||
| A children's global assessment scale (CGAS) | Q28271291 | ||
| Inositol phosphates and cell signalling | Q29615042 | ||
| Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data | Q29616031 | ||
| A rating scale for mania: reliability, validity and sensitivity | Q29619299 | ||
| Bipolar disorder and myo-inositol: a review of the magnetic resonance spectroscopy findings | Q30980756 | ||
| Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research | Q30995022 | ||
| Decreased anterior cingulate myo-inositol/creatine spectroscopy resonance with lithium treatment in children with bipolar disorder | Q31969376 | ||
| Divalproex treatment for youth with explosive temper and mood lability: a double-blind, placebo-controlled crossover design | Q33180244 | ||
| Reduced NAA levels in the dorsolateral prefrontal cortex of young bipolar patients | Q33226446 | ||
| Proton magnetic resonance spectroscopy in youth with severe mood dysregulation | Q33327625 | ||
| Evidence for the involvement of the kainate receptor subunit GluR6 (GRIK2) in mediating behavioral displays related to behavioral symptoms of mania | Q33583988 | ||
| Differences in brain chemistry in children and adolescents with attention deficit hyperactivity disorder with and without comorbid bipolar disorder: a proton magnetic resonance spectroscopy study | Q33796986 | ||
| Brain-to-serum lithium ratio and age: an in vivo magnetic resonance spectroscopy study | Q33859307 | ||
| Risperidone in children with autism and serious behavioral problems | Q33960551 | ||
| Sex differences in response to lithium treatment | Q34018181 | ||
| Diagnosis of manic episodes in adolescent inpatients: structured diagnostic procedures compared to clinical chart diagnoses | Q34164707 | ||
| Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial | Q34341755 | ||
| Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. | Q34556434 | ||
| A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents | Q34568810 | ||
| The relationship between antidepressant prescription rates and rate of early adolescent suicide | Q34577873 | ||
| Defining clinical phenotypes of juvenile mania | Q35075420 | ||
| Family psychoeducation: an adjunctive intervention for children with bipolar disorder | Q35146061 | ||
| A transactional model of oppositional behavior: underpinnings of the Collaborative Problem Solving approach | Q35169605 | ||
| Modulators of the glutamatergic system: implications for the development of improved therapeutics in mood disorders | Q35176634 | ||
| Lithium treatment effects on Myo-inositol in adolescents with bipolar depression | Q35568324 | ||
| Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers | Q35770186 | ||
| Recognizing and monitoring adverse events of second-generation antipsychotics in children and adolescents | Q36328308 | ||
| N-acetylaspartate in neuropsychiatric disorders | Q36787721 | ||
| Meta-analysis of aggression and/or hostility-related events in children and adolescents treated with fluoxetine compared with placebo | Q36989891 | ||
| Low levels of N-acetyl aspartate in the left dorsolateral prefrontal cortex of pediatric bipolar patients | Q38440295 | ||
| Depressive symptoms by self-report in adolescence: phase I of the development of a questionnaire for depression by self-report | Q39268059 | ||
| Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy | Q40744586 | ||
| Lithium for prepubertal depressed children with family history predictors of future bipolarity: a double-blind, placebo-controlled study | Q40771273 | ||
| Fluoxetine in treatment of adolescent patients with autism: a longitudinal open trial | Q40845855 | ||
| Inducing lifestyle regularity in recovering bipolar disorder patients: results from the maintenance therapies in bipolar disorder protocol | Q40891095 | ||
| Behavioral efficacy of haloperidol and lithium carbonate. A comparison in hospitalized aggressive children with conduct disorder | Q42249064 | ||
| Lithium in hospitalized aggressive children with conduct disorder: a double-blind and placebo-controlled study | Q42279171 | ||
| Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder | Q42627601 | ||
| A double-blind placebo-controlled study of lithium in hospitalized aggressive children and adolescents with conduct disorder | Q43504977 | ||
| A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania | Q44168457 | ||
| Chronic treatment with both lithium and sodium valproate may normalize phosphoinositol cycle activity in bipolar patients | Q44204395 | ||
| Child- and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: development and preliminary results | Q44239566 | ||
| Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients | Q44323569 | ||
| Fluoxetine for the treatment of childhood anxiety disorders | Q44370632 | ||
| Decreased N-acetylaspartate in children with familial bipolar disorder | Q44466569 | ||
| Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents | Q44538148 | ||
| Pharmacokinetics of lithium carbonate in children | Q44586678 | ||
| Proton magnetic resonance spectroscopy of the frontal lobe and cerebellar vermis in children with a mood disorder and a familial risk for bipolar disorders | Q44772441 | ||
| Neurometabolic functioning and neuropsychological correlates in children with ADHD-H: preliminary findings. | Q44780622 | ||
| An excitement subscale of the Positive and Negative Syndrome Scale | Q44852773 | ||
| Brain metabolite concentration ratios in vivo: multisite reproducibility by single-voxel 1H MR spectroscopy | Q44917237 | ||
| Lithium treatment of acute mania in adolescents: a placebo-controlled discontinuation study | Q44987700 | ||
| Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders | Q45113253 | ||
| An open-label trial of escitalopram in pervasive developmental disorders | Q46396057 | ||
| Family-focused treatment versus individual treatment for bipolar disorder: results of a randomized clinical trial. | Q46507616 | ||
| Temporal change in N-acetyl-aspartate concentrations in adolescents with bipolar depression treated with lithium | Q46624948 | ||
| Reduced anterior cingulate glutamate in pediatric major depression: a magnetic resonance spectroscopy study. | Q46638511 | ||
| Lithium effects on brain glutamatergic and GABAergic systems of healthy volunteers as measured by proton magnetic resonance spectroscopy | Q46969270 | ||
| Prepubertal and early adolescent bipolarity differentiate from ADHD by manic symptoms, grandiose delusions, ultra-rapid or ultradian cycling | Q48725559 | ||
| Automatic repositioning of single voxels in longitudinal 1H MRS studies | Q48856038 | ||
| Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex | Q48951990 | ||
| Chronic versus episodic irritability in youth: a community-based, longitudinal study of clinical and diagnostic associations. | Q50926224 | ||
| Divalproex sodium reduces overall aggression in youth at high risk for bipolar disorder. | Q50934661 | ||
| Divalproex treatment of disruptive adolescents: a report of 10 cases. | Q51107943 | ||
| Efficacy of carbamazepine in assaultive patients with frontal lobe dysfunction. | Q51181324 | ||
| Carbamazepine versus propranolol in patients with uncontrolled rage outbursts: a random assignment study. | Q51235954 | ||
| Conners' Teacher Rating Scale for use in drug studies with children ? An empirical study | Q51300987 | ||
| Long-acting methylphenidate has an effect on aggressive behavior in children with attention-deficit/hyperactivity disorder. | Q51899718 | ||
| Prevalence, clinical correlates, and longitudinal course of severe mood dysregulation in children. | Q51911176 | ||
| Comorbidity between ADHD and symptoms of bipolar disorder in a community sample of children and adolescents. | Q51925235 | ||
| The Overt Aggression Scale: overview and guiding principles | Q52053708 | ||
| Best estimate of lifetime psychiatric diagnosis: a methodological study. | Q52098061 | ||
| Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. | Q52275733 | ||
| Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. | Q52900826 | ||
| The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation | Q69438858 | ||
| Carbamazepine in aggressive children with conduct disorder: a double-blind and placebo-controlled study | Q71781056 | ||
| Estimation of metabolite concentrations from localized in vivo proton NMR spectra | Q72319396 | ||
| Role of the family in recovery and major depression | Q72340514 | ||
| Stimulant treatment in young boys with symptoms suggesting childhood mania: a report from a longitudinal study | Q73125627 | ||
| Lithium-induced increase in human brain grey matter | Q73176044 | ||
| Lithium treatment of conduct disorders in adolescents | Q73196313 | ||
| Proton MR spectroscopy in children with bipolar affective disorder: preliminary observations | Q73802956 | ||
| A randomized study of family-focused psychoeducation and pharmacotherapy in the outpatient management of bipolar disorder | Q73918315 | ||
| Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? | Q74062508 | ||
| The Overt Agitation Severity Scale for the objective rating of agitation | Q74108874 | ||
| P433 | issue | 1 | |
| P921 | main subject | placebo | Q269829 |
| placebo-controlled trial | Q108853737 | ||
| P304 | page(s) | 61-73 | |
| P577 | publication date | 2009-02-01 | |
| P1433 | published in | Journal of Child and Adolescent Psychopharmacology | Q15756086 |
| P1476 | title | Randomized double-blind placebo-controlled trial of lithium in youths with severe mood dysregulation | |
| P478 | volume | 19 |
| Q36610730 | A Randomized Clinical Trial of an Integrative Group Therapy for Children With Severe Mood Dysregulation |
| Q33820624 | A novel group therapy for children with ADHD and severe mood dysregulation. |
| Q26991430 | A review of MR spectroscopy studies of pediatric bipolar disorder |
| Q37925811 | Clinical usefulness of second-generation antipsychotics in treating children and adolescents diagnosed with bipolar or schizophrenic disorders |
| Q30986822 | Comparison of bias-corrected covariance estimators for MMRM analysis in longitudinal data with dropouts. |
| Q51834345 | DSM Proposed Changes, Part II: Reclassifying Pediatric Bipolar Disorder |
| Q26853229 | DSM-5: disruptive mood dysregulation disorder |
| Q48284982 | Diagnosing bipolar disorder: Defining thresholds and setting boundaries |
| Q22252416 | Differentiating bipolar disorder-not otherwise specified and severe mood dysregulation |
| Q92897428 | Disruptive Mood Dysregulation Disorder Among Children and Adolescents |
| Q33726865 | Disruptive mood dysregulation disorder and chronic irritability in youth at familial risk for bipolar disorder |
| Q27009447 | Disruptive mood dysregulation disorder: a new diagnostic approach to chronic irritability in youth |
| Q28069569 | Disruptive mood dysregulation disorder: current insights |
| Q35607178 | Do we really know how to treat a child with bipolar disorder or one with severe mood dysregulation? Is there a magic bullet? |
| Q36879689 | Effects of lithium on cortical thickness and hippocampal subfield volumes in psychotic bipolar disorder |
| Q34803697 | Emotion dysregulation in attention deficit hyperactivity disorder |
| Q47283803 | Emotional face recognition in adolescent suicide attempters and adolescents engaging in non-suicidal self-injury |
| Q37809707 | Evidence for Use of Mood Stabilizers and Anticonvulsants in the Treatment of Nonaffective Disorders in Children and Adolescents |
| Q38818252 | Evidence-based treatments for youths with severely dysregulated mood: a qualitative systematic review of trials for SMD and DMDD. |
| Q34111063 | Helping Children Hospitalized for Rages |
| Q26739642 | Historical Underpinnings of Bipolar Disorder Diagnostic Criteria |
| Q88512378 | Improvements in Irritability with Open-Label Methylphenidate Treatment in Youth with Comorbid Attention Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder |
| Q88543713 | Interpersonal psychotherapy for mood and behavior dysregulation: Pilot randomized trial |
| Q35751499 | Irritability in children and adolescents: past concepts, current debates, and future opportunities |
| Q27011821 | Is bipolar always bipolar? Understanding the controversy on bipolar disorder in children |
| Q41474591 | Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines. |
| Q35925666 | Large positive effect of lithium on prefrontal cortex N-acetylaspartate in patients with bipolar disorder: 2-centre study |
| Q34346051 | Liquid risperidone in the treatment of rages in psychiatrically hospitalized children with possible bipolar disorder |
| Q48406708 | Lithium response viewed as a biomarker to predict developmental psychopathology in offspring with bipolar disorder: a commentary. |
| Q36578095 | Mood dysregulation |
| Q36864683 | Mood regulation in youth: research findings and clinical approaches to irritability and short-lived episodes of mania-like symptoms |
| Q42121078 | Morning light therapy for juvenile depression and severe mood dysregulation: study protocol for a randomized controlled trial |
| Q34398129 | Pediatric bipolar disorder versus severe mood dysregulation: risk for manic episodes on follow-up |
| Q47586182 | Practitioner Review: Definition, recognition, and treatment challenges of irritability in young people. |
| Q37768441 | Psychopharmacology of pediatric bipolar disorder. |
| Q47284608 | Putative mechanisms of action and clinical use of lithium in children and adolescents: a critical review. |
| Q33783427 | Review: magnetic resonance spectroscopy studies of pediatric major depressive disorder |
| Q34152823 | Severe mood dysregulation, irritability, and the diagnostic boundaries of bipolar disorder in youths |
| Q36247704 | Smaller hippocampal volumes in patients with bipolar disorder are masked by exposure to lithium: a meta-analysis |
| Q90080343 | The Clinician Affective Reactivity Index: Validity and Reliability of a Clinician-Rated Assessment of Irritability |
| Q36707994 | The Effectiveness and Tolerability of Central Nervous System Stimulants in School-Age Children with Attention-Deficit/Hyperactivity Disorder and Disruptive Mood Dysregulation Disorder Across Home and School |
| Q47114336 | The International Society for Bipolar Disorders Task Force report on pediatric bipolar disorder: Knowledge to date and directions for future research. |
| Q26747136 | The Status of Irritability in Psychiatry: A Conceptual and Quantitative Review |
| Q34492314 | Treatment Options for the Cardinal Symptoms of Disruptive Mood Dysregulation Disorder |
| Q34206467 | Treatment of Pediatric Bipolar Disorder: A Review |
| Q50476458 | [Disruptive Mood Dysregulation Disorder: a controversial new diagnostic entity in the DSM-5]. |
Search more.